Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure

Journal of Cardiac Failure

Volumn 10, Issue 2, 2004, Pages 115-119

  Chen, Horng H ^a   Redfield, Margaret M ^a   Nordstrom, Lynda J ^a   Horton, Darlene P ^b   Burnett Jr , John C ^a  

^a MAYO CLINIC   (United States)

^b SCIOS INC   (United States)

Author keywords

cGMP; kidney; Natriuretic peptides

Indexed keywords

ALDOSTERONE; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; NESIRITIDE; RECOMBINANT HORMONE; RENIN;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEART OUTPUT; HEART RATE; HORMONE BLOOD LEVEL; HUMAN; HUMORAL IMMUNITY; MALE; MICTURITION DISORDER; NATRIURESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

AGED; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; NATRIURETIC PEPTIDE, BRAIN; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 3042754038     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2003.08.011     Document Type: Article

References (19)

1. Grantham J.A., Borgeson D.D., Burnett J.C. Jr. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure. Am J Physiol. 272:1997;R1077-R1083
2. Sudoh T., Kangawa K., Minamino N., Matsuo H. A new natriuretic peptide in porcine brain. Nature. 332:1988;78-80
3. Minamino N., Kangawa K., Matsuo H. Isolation and identification of a higher molecular weight brain natriuretic peptide in porcine cardiac atrium. Biochem Biophys Res Commun. 157:1988;402-409
4. Chang M., Lowe D.G., Lewis M., Hellmiss R., Chen E., Goeddel D.V. Differential activation by atrial and brain natriuretic peptide of two different receptor guanylate cyclase. Nature. 341:1989;69-72
5. Yamamoto K., Burnett J.C. Jr., Redfield M. Effects of the endogenous natriuretic peptide system on ventricular and coronary function in the failing heart. Am J Physiol. 273:1997;2406-2414
6. Hobbs R.E., Miller L.W., Bott-Silverman C., James K.B., Rincon G., Grossbard E.B. Hemodynamics effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 78:1996;896-901
7. Marcus L.S., Hart D., Packer M., Yushak M., Medina N., Danziger R.S., et al. Hemodynamics and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. Circulation. 94:1996;3184-3189
8. Colucci W.S., Elkayam U., Horton D.P., Abraham W.T., Bourge R.C., Johnson A.D., et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. [erratum N Engl J Med 2000;343:1504; N Engl J Med 2000; 343:896] N Engl J Med. 343:2000;246-253
9. Wei C.M., Kao P.C., Lin J., Heublein D.M., Schaff H.V., Burnett J.C. Jr. Circulating beta-atrial natriuretic peptide in congestive heart failure in humans. Circulation. 88:1993;1016-1020
10. Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure - a randomized controlled trial. JAMA. 287:2002;1531-1540
11. Colucci W.S., Elkayam U., Horton D.P., Abraham W.T., Bourge R.C., Johnson A.D., et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med. 343:2000;246-253
12. Chen H.H., Grantham J.A., Schirger J.A., Jougasaki M., Redfield M., Burnett J.C. Jr. Subcutaneous administration of brain natriuretic peptide in experimental heart failure. J Am Coll Cardiol. 36:2000;1706-1712
13. Steiner A.L., Parker C.W., Kipnis D.M. Radioimmunoassay for cyclic nucleotidase. J Biol Chem. 247:1972;1106-1113
14. Haber E., Koerner T., Page L.B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiological measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 29:1969;1349-1355
15. Sando J., Haber E. A direct microassay for aldosterone in plasma extracts. J Clin Endocrinol Metab. 47:1978;391-396
16. Johnson W., Omland T., Hall C., Lucas C., Myking O., Collins C., et al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol. 39:2002;1623-1629
17. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 341:1999;709-717
18. Brunner-La Roca H., Kaye D., Woods R., Hastings J., Esler M. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol. 37:2001;1221-1227
19. Chen H.H., Burnett J.C. Jr. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Proc Assoc Am Phys. 111:1999;406-416